Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line.
Saafan H, Alahdab A, Michelet R, Gohlke L, Ziemann J, Holdenrieder S, McLaughlin KM, Wass MN, Cinatl J Jr, Michaelis M, Kloft C, Ritter CA. Saafan H, et al. Among authors: holdenrieder s. Cells. 2021 Mar 24;10(4):716. doi: 10.3390/cells10040716. Cells. 2021. PMID: 33804833 Free PMC article.
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patients.
Ojara FW, Henrich A, Frances N, Nassar YM, Huisinga W, Hartung N, Geiger K, Holdenrieder S, Joerger M, Kloft C. Ojara FW, et al. Among authors: holdenrieder s. CPT Pharmacometrics Syst Pharmacol. 2023 Nov;12(11):1714-1725. doi: 10.1002/psp4.12937. Epub 2023 Feb 27. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36782356 Free PMC article.
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol.
Mc Laughlin AM, Schmulenson E, Teplytska O, Zimmermann S, Opitz P, Groenland SL, Huitema ADR, Steeghs N, Müller L, Fuxius S, Illerhaus G, Joerger M, Mayer F, Fuhr U, Holdenrieder S, Hempel G, Scherf-Clavel O, Jaehde U, Kloft C, For The On-Target Study Consortium. Mc Laughlin AM, et al. Among authors: holdenrieder s. Cancers (Basel). 2021 Dec 14;13(24):6281. doi: 10.3390/cancers13246281. Cancers (Basel). 2021. PMID: 34944899 Free PMC article.
Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line.
Ungerer V, Bronkhorst AJ, Uhlig C, Holdenrieder S. Ungerer V, et al. Among authors: holdenrieder s. Diagnostics (Basel). 2022 Aug 4;12(8):1896. doi: 10.3390/diagnostics12081896. Diagnostics (Basel). 2022. PMID: 36010246 Free PMC article.
271 results